← All Sponsors
SPONSOR

NMD Pharma A/S

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Myasthenia GravisMyasthenia Gravis, MuSK
NCT06414954 Phase 2
Recruiting

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

Myasthenia Gravis
United States, Belgium, Denmark View Trial →